Innovation

Steroidal Anti-Hormone Hybrids as Novel Therapeutic Agents

Northeastern University
posted on 05/19/2009

This invention provides an example of a hybrid compound that can be used to modulate disease processes. The invention describes the development of new chemotherapeutic agents by coupling two biologically active compounds in order to make a single hybrid agent.


Innovation Details
 

File Number: INV-0922/US 

Other Information:

Investigator(s)
Robert Hanson

Contact
Susan Riley Keyes, s.keyes@neu.edu


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Abi Barrow at Northeastern University for more information.

Request more info via email request more info
People

Case Manager:

Abi Barrow Abi Barrow

Innovations (0)

Download Technology Brief (PDF)


[?]
Followed By

Follow this innovation



No one is following this innovation.

Organization
3495

Northeastern University


Communities
Profile
Related Tags

Find more innovations

February 11, 2009

7,868 members 17,196 innovations 152 organizations

Browse

Scott Steele, coordinator of the CTSA-IP initiative and director of research alliances at the University of Rochester

"With more than 3,700 innovations from CTSA member institutions already on the iBridge Network, we're garnering worldwide exposure for the breakthroughs our researchers are accomplishing while moving toward our goal of increasing human health through clinical and translational research."  read more...